Cardiometabolic Diseases Cardiometabolic Diseases We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.
Interconnected CRM conditions Interconnected CRM conditions Learn about the interconnectivity between the heart, kidney and metabolic systems
Open Innovation at Boehringer Ingelheim Open Innovation at Boehringer Ingelheim Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Drug Discovery at Boehringer Ingelheim Drug Discovery at Boehringer Ingelheim Find out more about the drug discovery process at Boehringer Ingelheim
Ileitis prevention vaccination Lawsonia intracellularis pig Ileitis prevention vaccination Lawsonia intracellularis pig Cause, impact and prevention: Learn the essentials about Ileitis
The beginning of the end for KRAS cancers The beginning of the end for KRAS cancers Learn how Darryl McConnell & his team are tackling the “the beating heart of cancer”
Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19 Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19 Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
preventive care cat veterinarian preventive care cat veterinarian What can we all, cat owners or veterinarians, do to promote cat health? Click to find out!
All the same, yet different – Ethnic Equality Month All the same, yet different – Ethnic Equality Month Mohammed Samy, Human Pharma Marketing Team Lead from Amsterdam explains how ethnic diversity creates collective strength and sustainable growth
Meet BIs Brains Michael Sand Meet BIs Brains Michael Sand Dr. Michael Sand, Senior Clinical Program Leader, CNS at Boehringer Ingelheim shares his view on the complexities of the CNS research landscape.
Supporting local communities by offsetting carbon emissions Supporting local communities by offsetting carbon emissions Boehringer Ingelheim partially offsets its carbon emissions by partnering with ClimateSeed
Interview: Excellence in stem cell treatments Interview: Excellence in stem cell treatments Acquisition of GST reflects the potential of biotechnology research. Goal is to provide breakthrough therapies for diseases in companion animals.
“LastMile” – improving through digital “LastMile” – improving through digital “LastMile” – improving through digital
Winners of 2020 BVDzero Case Awards announced Winners of 2020 BVDzero Case Awards announced Winners of 2020 BVDzero Case Awards announced
Heart murmur in dogs: symptoms and how to treat it Heart murmur in dogs: symptoms and how to treat it Monitoring your dog’s heart can save its life
Cat care interview veterinarian Dr Susan Little Cat care interview veterinarian Dr Susan Little World-renowned feline healthcare specialist Dr. Susan Little shares her thoughts on latest trends in cat care.
EHS management approach EHS management approach We protect our employees, facilities and the environment from harmful influences, conserve natural resources and promote environmental awareness
Advancing regenerative medicine Advancing regenerative medicine Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Lead with Pride – for the Benefit of All. Lead with Pride – for the Benefit of All. How Inclusive Leadership advocates for Acceptance and creating a Sense of Belonging
Afrika Kommt! - The Ripple Effect Afrika Kommt! - The Ripple Effect What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
1948-1990: Going global 1948-1990: Going global The Boehringer Ingelheim history from 1948-1990, with milestones
1990-2022: Value through Innovation 1990-2022: Value through Innovation The Boehringer Ingelheim history from 1990 to 2022, with milestones